Avalyn Pharma Inc. · NASDAQ:AVLN
Novo Holdings A/S reported a 8.80% stake in Avalyn Pharma Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Novo Holdings A/S reported a 8.80% stake in Avalyn Pharma Inc., 3,883,289 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 8.80%
- Shares
- 3,883,289
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Novo Holdings A/S | 8.80% | 3,883,289 |
Source
Related
- Avalyn Pharma Inc.
- Novo Holdings A/S
- Avalyn Pharma Inc. shareholders
- Schedule 13G · Norwest Venture Partners XV, LP · Aug 11, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13D · Montanova Capital, LLC · May 8, 2026
- Schedule 13D · SR One Capital Management, LLC · May 8, 2026
- Schedule 13G · Perceptive Advisors LLC · May 7, 2026